Back to Journals » Pharmacogenomics and Personalized Medicine

Pharmacogenomics and Personalized Medicine

ISSN: 1178-7066


Journal Articles:

- 628 records -

Pharmacogenomic Analysis of CYP3A5*3 and Tacrolimus Trough Concentrations in Vietnamese Renal Transplant Outcomes

Nguyen TVA, Le BH, Nguyen MT, Le VT, Tran VT, Le DT, Vu DAM, Truong QK, Le TH, Nguyen HTL

Pharmacogenomics and Personalized Medicine 2024, 17:53-64

Published Date: 3 February 2024

The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period

Lilic J, Marjanovic VG, Budic I, Stefanovic N, Stokanovic D, Marjanovic GT, Jevtovic-Stoimenov T, Golubovic M, Zecevic M, Velickovic-Radovanovic R

Pharmacogenomics and Personalized Medicine 2024, 17:41-49

Published Date: 30 January 2024

FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults

Zhang M, Chen F, Feng S, Liu X, Wang Z, Shen N, Meng L, Zhu D, Zhu Z

Pharmacogenomics and Personalized Medicine 2024, 17:27-40

Published Date: 19 January 2024

circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of Bladder Cancer

Zhou H, Cui X, Zhu L, Xu Z, Wang Z, Shao J

Pharmacogenomics and Personalized Medicine 2024, 17:1-11

Published Date: 5 January 2024

Challenges in DPYD Test Implementation in Patients Treated with Fluoropyrimidines are DPYD Genotype Arriving on Time? [Letter]

López López-Cepero M, Obrador de Hevia A, Guillot Morales M

Pharmacogenomics and Personalized Medicine 2023, 16:1145-1147

Published Date: 28 December 2023

Heme Metabolism-Related Gene TENT5C is a Prognostic Marker and Investigating Its Immunological Role in Colon Cancer

Han W, Li C, Wang Y, Huo B, Li W, Shi W

Pharmacogenomics and Personalized Medicine 2023, 16:1127-1143

Published Date: 23 December 2023

BICDL1 Predicts Poor Prognosis and is Correlated with Methylation and Immune Infiltration in Colorectal Cancer

Luo H, Luo J, Ding N, Zhang T, He Y

Pharmacogenomics and Personalized Medicine 2023, 16:1109-1126

Published Date: 22 December 2023

Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions

Kolli P, Kelley G, Rosales M, Faden J, Serdenes R

Pharmacogenomics and Personalized Medicine 2023, 16:1097-1108

Published Date: 21 December 2023

A Case of Floating-Harbor Syndrome with “Growth and Language Development Delay” as Its Clinical Manifestation

Yang YC, Tang Q, Yan LJ, Zhang SB, Ye XM, Gong D, Zou L, Wen XL

Pharmacogenomics and Personalized Medicine 2023, 16:1091-1096

Published Date: 15 December 2023

Novel Autophagy-Related Blood Biomarkers Associated with Immune Cell Infiltration in Ankylosing Spondylitis

Song H, Liu H, Li X, Lv B, Tang Z, Chen Q, Zhang D, Wang F

Pharmacogenomics and Personalized Medicine 2023, 16:1055-1066

Published Date: 5 December 2023

Identification of P3H1 as a Predictive Prognostic Biomarker for Bladder Urothelial Carcinoma Based on the Cancer Genome Atlas Database

Zhang Y, Chen Y, Chen Z, Zhou X, Chen S, Lan K, Wang Z, Zhang Y

Pharmacogenomics and Personalized Medicine 2023, 16:1041-1053

Published Date: 1 December 2023

Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review

Oliva A, Cao D, Spirito A, Nicolas J, Pileggi B, Kamaleldin K, Vogel B, Mehran R

Pharmacogenomics and Personalized Medicine 2023, 16:973-990

Published Date: 3 November 2023

Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma

Shen GY, Yang PJ, Zhang WS, Chen JB, Tian QY, Zhang Y, Han B

Pharmacogenomics and Personalized Medicine 2023, 16:959-972

Published Date: 4 November 2023

rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population

Dai J, Zhang S, Shi Y, Xu J, Liu W, Yang J, Shi L, Yan Z, Li C

Pharmacogenomics and Personalized Medicine 2023, 16:933-948

Published Date: 30 October 2023

Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans

Zhou Y, Cai H, Huang L, Wang M, Liu R, Wang S, Qin Y, Yao C, Hu Z

Pharmacogenomics and Personalized Medicine 2023, 16:913-924

Published Date: 24 October 2023

A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant [Letter]

Furqoni AH, Fajarwati I, Poetranto AL

Pharmacogenomics and Personalized Medicine 2023, 16:911-912

Published Date: 25 October 2023

Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes

Mouhrach I, Bouguenouch L, Kamal A, Meriame A, El Khorb N, El Azami El Idrissi M, Akoudad H, Bekkari H

Pharmacogenomics and Personalized Medicine 2023, 16:901-909

Published Date: 2 October 2023

Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies

Rani DS, Kasala A, Dhandapany PS, Muthusami U, Kunnoth S, Rathinavel A, Ayapati DR, Thangaraj K

Pharmacogenomics and Personalized Medicine 2023, 16:883-893

Published Date: 20 September 2023

Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation

Jarrar Y, Abudahab S, Abdul-Wahab G, Zaiter D, Madani A, Abaalkhail SJ, Abulebdah D, Alhawari H, Musleh R, Lee SJ

Pharmacogenomics and Personalized Medicine 2023, 16:847-857

Published Date: 13 September 2023

Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer

He H, Ma H, Chen Z, Chen J, Wu D, Lv X, Zhu J

Pharmacogenomics and Personalized Medicine 2023, 16:835-846

Published Date: 13 September 2023

A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant

Tang Q, Gong D, Ye XM, Xu JR, Yang YC, Yan LJ, Zou L, Wen XL

Pharmacogenomics and Personalized Medicine 2023, 16:817-823

Published Date: 8 September 2023

A Case-Control Study of the Relationship Between Genetic Polymorphism and Cretinism in Xinjiang

Huang J, Wu H, Zhao G, Ma Y, An Y, Sun L, Li F, Wang S

Pharmacogenomics and Personalized Medicine 2023, 16:785-794

Published Date: 23 August 2023

Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy

Wu J, Ren L, Huang X, Hu L, Zhang L, Xie D, Li Z, Han N, Huang S

Pharmacogenomics and Personalized Medicine 2023, 16:759-766

Published Date: 17 August 2023

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer

Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, Ding J

Pharmacogenomics and Personalized Medicine 2023, 16:747-758

Published Date: 9 August 2023

Association Between HTRA1, GAS6 and IFNGR2 Gene Polymorphisms and Stroke Susceptibility in the Chinese Han Population

Zhang F, Peng H, Fu C, Deng Y, Zhang M, Li W, Zhong J, Zhou Q, Huang L, Xiao S, Zhao J

Pharmacogenomics and Personalized Medicine 2023, 16:717-727

Published Date: 7 July 2023

Impact of TREM1 Variants on the Risk and Prognosis of Glioma in the Chinese Han Population

Hu M, Wei J, Hao J, Jin T, Li B

Pharmacogenomics and Personalized Medicine 2023, 16:707-715

Published Date: 3 July 2023

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study

Bollinger A, Stäuble CK, Jeiziner C, Wiss FM, Hersberger KE, Lampert ML, Meyer zu Schwabedissen HE, Allemann SS

Pharmacogenomics and Personalized Medicine 2023, 16:693-706

Published Date: 3 July 2023

Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?

Vears DF, Savulescu J, Christodoulou J, Wall M, Newson AJ

Pharmacogenomics and Personalized Medicine 2023, 16:681-691

Published Date: 1 July 2023

More articles